Cleared Traditional

K150754 - ARGOS

K150754 is an FDA 510(k) clearance for ARGOS, manufactured by Santec Corporation. The device is a Class 2 Ophthalmic device with product code MXK cleared through the Traditional 510(k) pathway after a 193-day FDA review.

K150754 · Santec Corporation · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2015
Decision
193d
Days
Class 2
Risk

K150754 is an FDA 510(k) clearance for the ARGOS. Classified as Device, Analysis, Anterior Segment (product code MXK), Class II - Special Controls.

Submitted by Santec Corporation (Komaki, JP). The FDA issued a Cleared decision on October 2, 2015 after a review of 193 days - an extended review cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.1850 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ophthalmic review framework, consistent with the majority of Class II 510(k) submissions.

View all Santec Corporation devices

FDA 510(k) Submission Details - K150754

510(k) Number K150754 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 23, 2015
Decision Date October 02, 2015
Days to Decision 193 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
83d slower than avg
Panel avg: 110d · This submission: 193d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MXK Device Classification - Class 2, Special Controls

Product Code MXK Device, Analysis, Anterior Segment
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.1850
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - MXK Device, Analysis, Anterior Segment

All 14
Devices cleared under the same product code (MXK) and FDA review panel - the closest regulatory comparables to K150754.
Galilei G6 Lens Professional
K182659 · Sis Ag, Surgical Instrument Systems · Jul 2019
ARGOS
K191051 · Santec Corporation · May 2019
Pentacam AXL
K152311 · Oculus Optikgerate GmbH · Jan 2016
PACHYCAM
K041841 · Oculus Optikgerate GmbH · Jan 2005
HEIDELBERG RETINA TOMOGRAPH II / ROSTOCK CORNEA MODULE (HRT II / RCM)
K042742 · Heidelberg Engineering · Oct 2004
ANTERIOR EYE-SEGMENT ANALYSIS SYSTEM
K991284 · Nidek, Inc. · Aug 1999